3,4-dihydroxyphenylacetic acid has been researched along with Apnea, Obstructive Sleep in 2 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
| Excerpt | Relevance | Reference |
|---|---|---|
| "It is unclear why daytime sleepiness is not always present in OSA patients even if their sleep is disrupted from the perspective of polysomnographic findings." | 1.40 | Correlation of daytime sleepiness with urine metabolites in patients with obstructive sleep apnea. ( Kim, DK; Kim, JW; Lee, G; Nguyen, DT; Paik, MJ; Rhee, CS; Yoon, IY, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krief, S | 1 |
| Berrebi-Bertrand, I | 1 |
| Nagmar, I | 1 |
| Giret, M | 1 |
| Belliard, S | 1 |
| Perrin, D | 1 |
| Uguen, M | 1 |
| Robert, P | 1 |
| Lecomte, JM | 1 |
| Schwartz, JC | 1 |
| Finance, O | 1 |
| Ligneau, X | 1 |
| Paik, MJ | 1 |
| Kim, DK | 1 |
| Nguyen, DT | 1 |
| Lee, G | 1 |
| Rhee, CS | 1 |
| Yoon, IY | 1 |
| Kim, JW | 1 |
2 other studies available for 3,4-dihydroxyphenylacetic acid and Apnea, Obstructive Sleep
| Article | Year |
|---|---|
Pitolisant, a wake-promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Amphetamine; Animals; Carbamates; Corp | 2021 |
Correlation of daytime sleepiness with urine metabolites in patients with obstructive sleep apnea.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Biomarkers; Disorders of Excessive Somnolence; Dopamine; Fema | 2014 |